PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,344,247 | -36.8% | 23,274,760 | +0.6% | 0.01% | -28.6% |
| Q2 2023 | $307,586,001 | +19.2% | 23,126,767 | +3.8% | 0.01% | 0.0% |
| Q1 2023 | $257,952,491 | +55.5% | 22,275,690 | +9.8% | 0.01% | +40.0% |
| Q4 2022 | $165,882,506 | +45.3% | 20,279,035 | +3.1% | 0.01% | +66.7% |
| Q3 2022 | $114,138,000 | +21.6% | 19,662,066 | -7.4% | 0.00% | 0.0% |
| Q2 2022 | $93,887,000 | -48.3% | 21,241,318 | +6.5% | 0.00% | -25.0% |
| Q1 2022 | $181,499,000 | -55.3% | 19,945,092 | +0.5% | 0.00% | -55.6% |
| Q4 2021 | $406,230,000 | -11.7% | 19,854,876 | +10.3% | 0.01% | -18.2% |
| Q3 2021 | $459,814,000 | -27.7% | 17,996,649 | -1.1% | 0.01% | -31.2% |
| Q2 2021 | $636,346,000 | +7.5% | 18,196,904 | +2.4% | 0.02% | 0.0% |
| Q1 2021 | $591,788,000 | +59.3% | 17,766,083 | +24.1% | 0.02% | +45.5% |
| Q4 2020 | $371,468,000 | +262.9% | 14,320,299 | +38.1% | 0.01% | +266.7% |
| Q3 2020 | $102,352,000 | +271.8% | 10,369,976 | +30.0% | 0.00% | +200.0% |
| Q2 2020 | $27,526,000 | +20.5% | 7,978,476 | +6.8% | 0.00% | 0.0% |
| Q1 2020 | $22,848,000 | -43.6% | 7,467,151 | -5.2% | 0.00% | 0.0% |
| Q4 2019 | $40,485,000 | +0.6% | 7,876,485 | +1.0% | 0.00% | 0.0% |
| Q3 2019 | $40,253,000 | -13.2% | 7,801,024 | +1.8% | 0.00% | -50.0% |
| Q2 2019 | $46,382,000 | -15.7% | 7,666,529 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $55,028,000 | -0.3% | 7,611,207 | +2.1% | 0.00% | 0.0% |
| Q4 2018 | $55,182,000 | +61.6% | 7,457,125 | +18.1% | 0.00% | +100.0% |
| Q3 2018 | $34,148,000 | +62.1% | 6,311,846 | +6.4% | 0.00% | 0.0% |
| Q2 2018 | $21,067,000 | +97.3% | 5,934,574 | +13.9% | 0.00% | – |
| Q1 2018 | $10,679,000 | -17.1% | 5,209,868 | +6.7% | 0.00% | -100.0% |
| Q4 2017 | $12,886,000 | -45.8% | 4,881,321 | +7.8% | 0.00% | 0.0% |
| Q3 2017 | $23,782,000 | +70.0% | 4,530,024 | +15.3% | 0.00% | 0.0% |
| Q2 2017 | $13,988,000 | -25.8% | 3,929,300 | +7.8% | 0.00% | 0.0% |
| Q1 2017 | $18,850,000 | +54.0% | 3,646,084 | +13.2% | 0.00% | 0.0% |
| Q4 2016 | $12,241,000 | -56.6% | 3,221,452 | +2.3% | 0.00% | -50.0% |
| Q3 2016 | $28,207,000 | +37.2% | 3,148,148 | +7.7% | 0.00% | +100.0% |
| Q2 2016 | $20,559,000 | -4.5% | 2,922,446 | +15.4% | 0.00% | 0.0% |
| Q1 2016 | $21,535,000 | -29.5% | 2,533,496 | +8.8% | 0.00% | -50.0% |
| Q4 2015 | $30,562,000 | +309.3% | 2,327,597 | +14.1% | 0.00% | – |
| Q3 2015 | $7,466,000 | -32.3% | 2,040,068 | +6.5% | 0.00% | -100.0% |
| Q2 2015 | $11,029,000 | +3.9% | 1,914,671 | +5.3% | 0.00% | 0.0% |
| Q1 2015 | $10,616,000 | -16.8% | 1,817,658 | +11.7% | 0.00% | 0.0% |
| Q4 2014 | $12,757,000 | +72.8% | 1,627,174 | +8.2% | 0.00% | 0.0% |
| Q3 2014 | $7,381,000 | -18.0% | 1,503,191 | +3.2% | 0.00% | 0.0% |
| Q2 2014 | $9,001,000 | +24.2% | 1,456,433 | +7.5% | 0.00% | 0.0% |
| Q1 2014 | $7,249,000 | +38.3% | 1,354,866 | +35.2% | 0.00% | – |
| Q4 2013 | $5,242,000 | +20.1% | 1,002,385 | +27.1% | 0.00% | – |
| Q3 2013 | $4,363,000 | +178.1% | 788,909 | +26.7% | 0.00% | – |
| Q2 2013 | $1,569,000 | – | 622,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |